Skip to main content
. 2019 Feb 14;75(5):835–842. doi: 10.1093/gerona/glz041

Table 2.

BMI and Serum Markers Before and After 1 Year of Vitamin D3 Supplementation

600 IU/d 2,000 IU/d 4,000 IU/d p
Baseline Final Change Baseline Final Change Baseline Final Change Group Time Group × Time
BMI (kg/m2) 29.2 ± 2.6 28.6 ± 3.3 −0.6 ± 1.6 31.5 ± 4.3 30.7 ± 4.3 −0.8 ± 1.6 29.0 ± 3.0 28.2 ± 3.1 −0.7 ± 1.8 .115 .004 .940
25OHD (ng/mL) 26.7 ± 5.0 30.2 ± 5.6 3.5 ± 4.4a,b 28.2 ± 5.3 36.0 ± 4.9 7.8 ± 7.3a 27.4 ± 4.2 40.8 ± 7.0 13.4 ± 6.6b .006 .001 < .001
PTH (ng/mL) 36.3 ± 9.5 33.5 ± 8.4 −2.8 ± 4.6 38.8 ± 16.6 34.8 ± 8.5 −4.0 ± 14.7 38.7 ± 16.2 31.0 ± 8.0 −7.7 ± 12.8 .846 .010 .527
Estradiol (pmol/L) 11.9 ± 4.7 11.2 ± 3.8 −0.7 ± 2.5 16.2 ± 6.1 13.9 ± 5.8 −1.3 ± 6.0 16.1 ± 6.0 14.5 ± 4.5 −2.8 ± 5.9 .092 .048 .761
OC (ng/mL) 6.4 ± 2.5 6.7 ± 2.4 0.3 ± 3.1 5.7 ± 1.6 6.0 ± 2.4 0.3 ± 2.5 5.6 ± 2.5 7.9 ± 2.6 2.5 ± 2.9 .409 .027 .118
ucOC (ng/mL) 2.2 ± 0.9 2.3 ± 0.7 0.02 ± 0.9 1.8 ± 0.8 2.3 ± 1.2 0.5 ± 1.3 1.9 ± 0.7 2.3 ± 1.1 0.36 ± 1.22 .926 .104 .485
42 (pg/mL) 14.0 ± 31.9 10.1 ± 20.4 −3.9 ± 12.9 12.0 ± 33.8 13.5 ± 38.2 1.5 ± 4.4 6.7 ± 8.0 7.0 ± 6.5 −0.2 ± 1.9 .893 .688 .023
40 (pg/mL) 12.3 ± 14.3 16.6 ± 23.7 4.3 ± 17.9 21.1 ± 24.0 25.6 ± 28.4 3.9 ± 10.7 42.5 ± 25.0 55.2 ± 11.4 12.7 ± 24.7 .002 .047 .219
42/Aβ40 0.9 ± 1.6 1.3 ± 2.9 0.3 ± 2.01 1.1 ± 3.6 0.9 ± 3.1 −0.2 ± 0.5 0.2 ± 0.3 0.1 ± 0.1 −0.1 ± 0.2 .541 .838 .555

Notes: Values represent means ± SD (n = 42). Baseline levels were taken after 4 weeks of stabilization with 600 IU/d vitamin D intake in all participants. Screening level of 25OHD before daily multivitamin was 22.6 ± 5.8 ng/mL and did not differ significantly between groups. Different superscript letters in the same row indicate significant differences between groups, p < .05. Bold values represent significance, p < .05. Aβ = amyloid beta; BMI = body mass index; 25OHD = 25-hydroxyvitamin D; OC = osteocalcin; PTH = parathyroid hormone.